摘要
目的:分析比较4种常见的人上皮性卵巢癌细胞系(A2780、CAOV-3、SKOV-3和ES-2)IL-6、IL-8分泌与他莫西芬(TAM)敏感性及MAPK、Akt活性和雌激素受体(ER)特异性位点磷酸化水平的关系,探讨IL-6、IL-8诱导卵巢癌细胞对内分泌治疗产生耐药的机制。方法:RT-PCR及ELISA法检测IL-6、IL-8的表达,MTT法分析卵巢癌细胞对TAM的敏感性,免疫印迹法测定MAPK、Akt活性及ER特异性位点的磷酸化水平。结果:(1)4种卵巢癌细胞除A2780细胞外均组成性分泌IL-6和IL-8,二者转录水平与其蛋白水平基本一致;(2)4种卵巢癌细胞对TAM的敏感性不同,其中A2780细胞最敏感,CAOV-3、SKOV-3和ES-2细胞则有不同程度的耐药性,其耐药倍数分别为4.99、3.76和2.66;(3)4种卵巢癌细胞的MAPK、Akt活性存在差异,CAOV-3细胞的二者活性最强,SKOV-3细胞的MAPK活性弱于ES-2细胞,而其Akt活性则强于ES-2细胞,A2780细胞未检测到二者有活性;(4)ER的第167位丝氨酸(Ser167)在四种卵巢癌细胞中均存在不同程度的磷酸化,ER的第118位丝氨酸(Ser118)除A2780细胞外亦存在不同程度的磷酸化。结论:卵巢癌细胞IL-6、IL-8的自分泌水平与其对TAM的敏感性呈负相关,与其MAPK、Akt活性和ER特异性位点(Ser167、Ser118)的磷酸化水平相一致。
AIM:To investigate the relationship of IL-6 and IL-8 secretion in four epithelial ovarian cancer cell lines(A2780,CAOV-3,SKOV-3 and ES-2)with their sensitivity to tamoxifen(TAM)as well as MAPK,Akt and estrogen receptor(ER)phosphorylation,and to explore the mechanism of endocrine therapy resistance caused by IL-6 and IL-8 in ovarian cancer cells.METHODS:Reverse transcription polymerase chain reaction(RT-PCR)and enzyme linked immunosorbent assay(ELISA)were performed to analyze the expression of IL-6 and IL-8.MTT assay was carried out to examine the response of ovarian cancer cells to TAM.Western blot was used to detect phosphorylated MAPK,Akt and ER.RESULTS:Except A2780 cells,three other ovarian cancer cells constitutively expressed IL-6 and IL-8.The mRNA levels of IL-6 and IL-8 correlated with their protein levels in four ovarian cancer cells.The four ovarian cancer cells showed different response to TAM.A2780 cells was the most responsive,whereas CAOV-3,SKOV-3 and ES-2 cells were TAM-resistant to a different degree.There was a notable difference in phosphorylated MAPK,Akt and ER(serine 118 and 167)among the four ovarian cancer cells.CONCLUSION:Autocrine production of IL-6 and IL-8 in epithelial ovarian cancer cell lines is inversely associated with cell response to TAM,and positively associated with phosphorylated MAPK,Akt and ER.
出处
《细胞与分子免疫学杂志》
CAS
CSCD
北大核心
2010年第1期21-24,共4页
Chinese Journal of Cellular and Molecular Immunology
基金
天津市自然科学基金项目(08JCYBJC06900)
武警医学院科学技术研究重点项目(WJZ2007-1)
博士科研启动金项目(WBS2007-6)